Classification
Product TypeProcessed Food
Product FormNon-alcoholic functional beverage (single-serve shot)
Industry PositionConsumer Packaged Beverage
Market
In Peru, “immunity-shot” products sit within the processed non-alcoholic beverage market and are typically positioned as wellness-oriented functional drinks sold in small, single-serve formats. Market access for industrialized foods and beverages (including imports) depends on obtaining/using the relevant sanitary registration pathway managed by DIGESA, commonly processed through the VUCE single-window workflow. Label compliance is a key commercial constraint: Peru’s front-of-pack octagon warnings apply to processed foods and beverages that exceed thresholds for sugar, sodium, saturated fat, or trans fats. “Immunity” positioning is also a high-scrutiny area because Peruvian consumer-protection enforcement has sanctioned unsupported therapeutic/health benefit advertising claims, increasing the compliance burden for claims and marketing content.
Market RoleDomestic consumer market supplied by both local manufacturing and imports
Domestic RoleConvenience-format functional beverage segment marketed for perceived wellness benefits (often vitamin C/antioxidant positioning) within the urban processed beverage market
Risks
Regulatory Compliance High“Immunity” positioning can be treated as a high-risk claim area in Peru: if labeling/advertising implies therapeutic, disease-prevention, or clinically-proven immune effects without objective substantiation, it can trigger enforcement actions (including sanctions and forced claim withdrawal). In parallel, product classification ambiguity (food vs. supplement/other regulated category) can disrupt sanitary registration and commercialization timelines.Use conservative, evidence-backed wording; avoid therapeutic/disease claims; keep a claim substantiation file; align product classification and dossier content early with the DIGESA sanitary registration pathway and local regulatory counsel.
Regulatory Compliance MediumFront-of-pack octagon warning labels are mandatory for processed beverages exceeding thresholds (e.g., sugar); non-compliance can force relabeling, delays, and retailer rejection.Run a pre-launch nutrient assessment against Peru’s octagon parameters; design compliant packaging (including sticker strategy where allowed) before shipment.
Documentation Gap MediumDIGESA sanitary registration submissions require specific dossier elements (accredited lab results, additive quantitative composition with international numbering where applicable, label draft, shelf-life, storage conditions, and imported-product free-sale documentation). Incomplete or inconsistent dossiers can delay commercialization.Build a Peru-specific dossier checklist mapped to DIGESA/VUCE requirements; verify lab accreditation acceptability; reconcile label, formulation, and additive declarations before submission.
Logistics MediumChilled or short-dated immunity-shot SKUs are exposed to border and last-mile delays that can compress sellable shelf-life and increase wastage risk.Prefer shelf-stable formats where feasible; if chilled, plan for faster clearance, buffer lead times, and validated cold-chain handling with temperature monitoring.
Sustainability- Environmental marketing (“eco”, “biodegradable”, “sustainable”) claims face scrutiny in Peru; unsupported “green” claims can trigger investigation and sanctions.
- Single-use packaging waste and recyclability claims can become compliance and reputational issues, especially for single-serve shot formats.
FAQ
¿Qué entidad regula el registro sanitario para comercializar bebidas procesadas como “immunity shots” en Perú?La autoridad sanitaria que gestiona el otorgamiento del registro sanitario para alimentos y bebidas industrializados (incluidos importados) es DIGESA, y el trámite suele canalizarse a través de la Ventanilla Única de Comercio Exterior (VUCE) cuando aplica.
¿Cuándo aplican los octógonos de advertencia en una bebida tipo “shot” en Perú?Aplican cuando la bebida procesada supera los parámetros establecidos para azúcar, sodio, grasas saturadas o contiene grasas trans; en esos casos debe llevar los octógonos correspondientes en el rotulado, según la implementación de la Ley N.° 30021.
¿Por qué es riesgoso vender un “immunity shot” con promesas de prevención o tratamiento de enfermedades en Perú?Porque INDECOPI ha sancionado y ordenado el cese de publicidad que atribuía propiedades terapéuticas o beneficios de salud no sustentados; por eso, los mensajes de “inmunidad” deben evitar afirmaciones clínicas o de prevención/tratamiento sin pruebas objetivas.